11 Nov 2022 , 12:17 PM
Net profit of Zydus Lifesciences declined 82.60% to Rs 522.50 crore in the quarter ended September 2022 as against Rs 3002.30 crore during the previous quarter ended September 2021. Sales rose 7.64% to Rs 3942.60 crore in the quarter ended September 2022 as against Rs 3662.60 crore during the previous quarter ended September 2021.
Particulars | Quarter Ended | ||
? | Sep. 2022 | Sep. 2021 | % Var. |
Sales | 3942.60 | 3662.60 | 8 |
OPM % | 20.68 | 24.56 | – |
PBDT | 824.60 | 922.70 | -11 |
PBT | 642.80 | 745.40 | -14 |
NP | 522.50 | 3002.30 | -83 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.